N. Håkan Wallén

2.5k total citations
51 papers, 2.0k citations indexed

About

N. Håkan Wallén is a scholar working on Cardiology and Cardiovascular Medicine, Pulmonary and Respiratory Medicine and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, N. Håkan Wallén has authored 51 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cardiology and Cardiovascular Medicine, 11 papers in Pulmonary and Respiratory Medicine and 11 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in N. Håkan Wallén's work include Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Blood properties and coagulation (10 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). N. Håkan Wallén is often cited by papers focused on Antiplatelet Therapy and Cardiovascular Diseases (25 papers), Blood properties and coagulation (10 papers) and Venous Thromboembolism Diagnosis and Management (10 papers). N. Håkan Wallén collaborates with scholars based in Sweden, United Kingdom and United States. N. Håkan Wallén's co-authors include Paul Hjemdahl, Nailin Li, P. T. Larsson, Marianne Yngen, Hirohito Kita, Deborah A. Weiler, Gerald J. Gleich, Jonas Schwieler, Anders Bröijersén and Nina Rehnqvist and has published in prestigious journals such as Circulation, The Journal of Immunology and Diabetes Care.

In The Last Decade

N. Håkan Wallén

51 papers receiving 1.9k citations

Peers

Countries citing papers authored by N. Håkan Wallén

Since Specialization

Citations

This map shows the geographic impact of N. Håkan Wallén's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Håkan Wallén with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Håkan Wallén more than expected).

Fields of papers citing papers by N. Håkan Wallén

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Håkan Wallén. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Håkan Wallén. The network helps show where N. Håkan Wallén may publish in the future.

Co-authorship network of co-authors of N. Håkan Wallén

This figure shows the co-authorship network connecting the top 25 collaborators of N. Håkan Wallén. A scholar is included among the top collaborators of N. Håkan Wallén based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Håkan Wallén. N. Håkan Wallén is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Inhibition of the renin–angiotensin system does not reduce platelet activity at rest or during stress in hypertension 2013 ·Journal of Hypertension ·Jonas Schwieler, Thomas Kahan, N. Håkan Wallén, Jürg Nussberger, Paul Hjemdahl	8
2	Atorvastatin has antithrombotic effects in patients with type 1 diabetes and dyslipidemia 2010 ·Thrombosis Research ·Sara Tehrani, Fariborz Mobarrez, Aleksandra Antovič, (unknown), Per‐Eric Lins, Ulf Adamson, Peter Henriksson, N. Håkan Wallén, Gun Jörneskog	52
3	Angiotensin II infusion in man is proinflammatory but has no short-term effects on thrombin generation in vivo 2009 ·Thrombosis Research ·(unknown), Thomas Kahan, Gun Jörneskog, Anders Bröijersén, N. Håkan Wallén	24
4	Can both EDTA and citrate plasma samples be used in measurements of fibrinogen and C-reactive protein concentrations? 2008 ·Clinical Chemistry and Laboratory Medicine (CCLM) ·Mika Skeppholm, N. Håkan Wallén, Margareta Blombäck, Anders Kallner	17
5	Comparison of two immunochemical assays for measuring thrombin-activatable fibrinolysis inhibitor concentration with a functional assay in patients with acute coronary syndrome 2007 ·Thrombosis Research ·Mika Skeppholm, N. Håkan Wallén, Karin Malmqvist, Anders Kallner, Jovan P. Antović	7
6	CRP, IL-6 and endothelin-1 levels in patients undergoing coronary artery bypass grafting. Do preoperative inflammatory parameters predict early graft occlusion and late cardiovascular events? 2006 ·International Journal of Cardiology ·Anders Hedman, P. T. Larsson, (unknown), N. Håkan Wallén, Rolf Nordlander, Bassem A. Samad	45
7	Meal‐induced platelet activation in Type 2 diabetes mellitus: effects of treatment with repaglinide and glibenclamide 2005 ·Diabetic Medicine ·Marianne Yngen, Claes‐Göran Östenson, Paul Hjemdahl, N. Håkan Wallén	26
8	Enhanced P-selectin expression and increased soluble CD40 Ligand in patients with Type 1 diabetes mellitus and microangiopathy: evidence for platelet hyperactivity and chronic inflammation 2004 ·Diabetologia ·Marianne Yngen, (unknown), Haitao Hu, Nailin Li, Paul Hjemdahl, N. Håkan Wallén	77
9	Prothrombotic responses to exercise are little influenced by clopidogrel treatment 2004 ·Thrombosis Research ·(unknown), N. Håkan Wallén, Haitao Hu, Nailin Li, Paul Hjemdahl	20
10	Enhanced leukocyte–platelet cross‐talk in Type 1 diabetes mellitus: relationship to microangiopathy 2004 ·Journal of Thrombosis and Haemostasis ·Haitao Hu, Nailin Li, Marianne Yngen, (unknown), N. Håkan Wallén, Paul Hjemdahl	51
11	Increased plasma fibrin gel porosity in patients with Type I diabetes during continuous subcutaneous insulin infusion 2003 ·Journal of Thrombosis and Haemostasis ·Gun Jörneskog, (unknown), N. Håkan Wallén, Marianne Yngen, Margareta Blombäck	37
12	Insulin Enhances Platelet Activation In Vitro 2001 ·Thrombosis Research ·Marianne Yngen, Nailin Li, Paul Hjemdahl, N. Håkan Wallén	22
13	Feedback on prescribing rate combined with problem-oriented pharmacotherapy education as a model to improve prescribing behaviour among general practitioners 2001 ·European Journal of Clinical Pharmacology ·Gunnar Nilsson, Paul Hjemdahl, (unknown), Sigurd Vitols, N. Håkan Wallén, Ingvar Krakau	43
14	Acute hyperglycemia increases soluble P-selectin in male patients with mild diabetes mellitus 2001 ·Blood Coagulation & Fibrinolysis ·Marianne Yngen, C-G Östenson, Nailin Li, Paul Hjemdahl, N. Håkan Wallén	34
15	Inflammatory and hemostatic markers in relation to cardiovascular prognosis in patients with stable angina pectoris 2000 ·Atherosclerosis ·Claes Held, Paul Hjemdahl, N. Håkan Wallén, Inge Björkander, Lennart Forslund, Björn Wiman, Nina Rehnqvist	44
16	Haemostatic markers, inflammatory parameters and lipids in male and female patients in the Angina Prognosis Study In Stockholm (APSIS). A comparison with healthy controls 1997 ·Journal of Internal Medicine ·Claes Held, Paul Hjemdahl, Nina Rehnqvist, N. Håkan Wallén, Lennart Forslund, Inge Björkander, Bo Angelin, B. Wiman	35
17	Effects of mental and physical stress on platelet function in patients with stable angina pectoris and healthy controls 1997 ·European Heart Journal ·N. Håkan Wallén, Claes Held, Nina Rehnqvist, Paul Hjemdahl	98
18	Influence of Different Anticoagulants on Platelet Aggregation in Whole Blood; A Comparison between Citrate, Low Molecular Mass Heparin and Hirudin 1997 ·Thrombosis Research ·N. Håkan Wallén, (unknown), (unknown), Anders Bröijersén	79
19	Calcium antagonist treatment, sympathetic activity and platelet function 1997 ·European Heart Journal ·Paul Hjemdahl, N. Håkan Wallén	38
20	On the Accurate Determination of Serotonin in Human Plasma 1993 ·Biochemical and Biophysical Research Communications ·Olof Beck, N. Håkan Wallén, Anders Bröijersén, P. T. Larsson, Paul Hjemdahl	57

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact